92 related articles for article (PubMed ID: 22091601)
1. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM
Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in Alzheimer's disease drug development.
Cummings JL
Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the amyloid beta-peptide in vivo--caveat emptor.
Thompson PW; Lockhart A
Drug Discov Today; 2009 Mar; 14(5-6):241-51. PubMed ID: 19135168
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's biomarker initiative hits its stride.
Miller G
Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
[No Abstract] [Full Text] [Related]
5. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
Masters CL; Cappai R; Barnham KJ; Villemagne VL
J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
[TBL] [Abstract][Full Text] [Related]
7. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
8. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease.
Zamrini E; De Santi S; Tolar M
Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748
[TBL] [Abstract][Full Text] [Related]
9. Imaging treatment effects in Alzheimer's disease.
Venneri A
Magn Reson Imaging; 2007 Jul; 25(6):953-68. PubMed ID: 17446028
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
11. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
12. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?
Nichols L; Pike VW; Cai L; Innis RB
Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944
[TBL] [Abstract][Full Text] [Related]
13. Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.
Sabbagh MN; Richardson S; Relkin N
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S109-18. PubMed ID: 18631986
[TBL] [Abstract][Full Text] [Related]
14. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
Meiner Z; Rosenmann H
Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
[TBL] [Abstract][Full Text] [Related]
15. Brain microbleeds and Alzheimer's disease: innocent observation or key player?
Cordonnier C; van der Flier WM
Brain; 2011 Feb; 134(Pt 2):335-44. PubMed ID: 21257651
[TBL] [Abstract][Full Text] [Related]
16. Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.
Bagnoli S; Piaceri I; Sorbi S; Nacmias B
Neurodegener Dis Manag; 2014; 4(1):73-81. PubMed ID: 24640981
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.
Dickerson BC; Sperling RA
NeuroRx; 2005 Apr; 2(2):348-60. PubMed ID: 15897955
[TBL] [Abstract][Full Text] [Related]
18. Disease-modifying trials in Alzheimer's disease: a European task force consensus.
Vellas B; Andrieu S; Sampaio C; Wilcock G;
Lancet Neurol; 2007 Jan; 6(1):56-62. PubMed ID: 17166802
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease drug development: translational neuroscience strategies.
Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
[TBL] [Abstract][Full Text] [Related]
20. Retina: source of the earliest biomarkers for Alzheimer's disease?
Krantic S; Torriglia A
J Alzheimers Dis; 2014; 40(2):237-43. PubMed ID: 24413614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
